A chimeric protein-based malaria vaccine candidate induces robust T cell responses against Plasmodium vivax MSP119

Fonseca, Jairo Andres; Cabrera-Mora, Monica; Singh, Balwan; Ferreira, Joseli Oliveira; Lima&; 160;Junior,&; 160;Josué&; 160;da&; 160;Costa; Calle, J. Mauricio Calvo; Lozano, Jose Manuel; Moreno, Alberto.
Artículo en Inglés | ARCA | ID: arc-17818

Documentos relacionados

  1. A Chimeric Plasmodium vivax Merozoite Surface Protein Antibody Recognizes and Blocks Erythrocytic P. cynomolgi Berok Merozoites <i>In Vitro</i>.
  2. A chimeric protein-based malaria vaccine candidate induces robust T cell responses against Plasmodium vivax MSP1<sub>19</sub>.
  3. Evaluation of a Plasmodium-Specific Carrier Protein To Enhance Production of Recombinant <i>Pf</i>s25, a Leading Transmission-Blocking Vaccine Candidate.
  4. Inclusion of the murine IgG&#954; signal peptide increases the cellular immunogenicity of a simian adenoviral vectored Plasmodium vivax multistage vaccine.
  5. Diversity covering AMA1-MSP119 fusion proteins as malaria vaccines.
  6. The structure of Plasmodium yoelii merozoite surface protein 119, antibody specificity and implications for malaria vaccine design.
  7. Genetic diversity and immunogenicity of the merozoite surface protein 1 C-terminal 19-kDa fragment of Plasmodium ovale imported from Africa into China.
  8. Specificity of the IgG antibody response to Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae, and Plasmodium ovale MSP1<sub>19</sub> subunit proteins in multiplexed serologic assays.
  9. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
  10. New insights for native production of MSP1(19), the disulfide-rich C-terminal fragment from Plasmodium falciparum merozoite surface protein 1.